October 2026
288 pages
6h 32m
English
Questions about the strength of your company’s leadership will inevitably rank among the board’s highest priorities. At the center of that discussion are three issues: whether the chief executive is the right person for the role, whether the senior leadership team is positioned to support that CEO effectively, and whether the board itself has the mix of experience and judgment the company needs.1
The first question became both critical and difficult for the board of GlaxoSmithKline (now GSK) when longtime CEO Jean-Pierre Garnier announced his intention to retire. In the absence of a clear favorite, the board found itself considering three internal candidates, each credible and capable of leading the company. ...
Read now
Unlock full access